Papers
7
Total Citations
654
H-Index
7
About
Bo Tang is a leading colorectal surgeon whose research is reshaping the landscape of minimally invasive rectal cancer surgery. His primary focus is on comparing the efficacy and outcomes of robotic-assisted versus laparoscopic surgical techniques. Tang's most significant contribution is the landmark REAL trial, a multicentre randomised controlled trial published in 2022, which has garnered over 450 citations and provides pivotal short-term outcome data for robotic versus laparoscopic surgery in middle and low rectal cancer. His work consistently demonstrates that robotic surgery can achieve comparable oncological results to laparoscopy while offering specific advantages, such as reduced intraoperative blood loss and more precise dissection. Tang has also rigorously investigated the learning curve for robotic total mesorectal excision and explored innovative techniques like transvaginal specimen extraction to further reduce surgical trauma. With a cumulative citation count exceeding 650, his meta-analyses and prospective studies on urogenital function preservation have established critical benchmarks for postoperative quality of life, solidifying his reputation as a key figure advancing the evidence base for robotic colorectal surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7